Last updated: 2026-09-26 16:53:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
DaVita Inc. (DVA) operates in the SERVICES-MISC HEALTH & ALLIED SERVICES, NEC sector and is listed on NYSE. The stock is currently priced at $178.43, with a market capitalization of $11.14B and a P/E ratio of 13.44. Over the past 52 weeks, its price has ranged from $101.00 to $247.49. This page covers its latest market performance, valuation, price trends and company information.
$11.14B | |
$175.38 | |
$247.49 | |
$10.22 | |
$174.67 | |
389.17K | |
813.46K | |
13.44 | |
$247.49 | |
$101.00 | |
2.84% | |
-- |
DaVita Inc. (DVA) last closed at $174.67 as of 2026-09-25 23:58:00, unchanged from the previous close of $174.67.
During the latest regular trading session, DVA traded between $10.22 and $247.49, with a volume of 389.17K shares. The closing price was near the upper end and near the middle of its 52-week range.
Over the past seven days, DaVita Inc. (DVA) moved from $183.09 to $178.43, representing a decline of 2.55% ($4.66).
The stock traded between $174.32 and $195.75 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 929.22 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 52.9%
DVA is currently trading at $178.43, placing it 52.9% of the way from its 52-week low of $101.00 to its 52-week high of $247.49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
| Industry | SERVICES-MISC HEALTH & ALLIED SERVICES, NEC |
| Employees | 78000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of DaVita Inc. (DVA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.